Abstract
Determining plasma concentrations of psychotherapeutic drugs is still relatively new, most of the studies having been done in the past 10–15 years. The idea of such monitoring is not new; when bromides were widely used in psychiatry and neurology, monitoring serum concentrations was recommended although seldom done. Technological advances have made routine monitoring possible. The only question that remains is when it is worth doing, assuming that the laboratories doing such work provide accurate determinations at a reasonable cost.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Amdisen, A. (1977). Serum level monitoring and clinical pharmacokinetics of lithium. Clin. Pharmacokinetics, 2, 73–92
Amsterdam, J., Brunswick, D.J. and Mendels, J. (1979). High dose desipramine plasma drug levels and clinical response. J. Clin. Psychiatry, 40, 141–3
Biggs, J.T. and Ziegler, V.E. (1977). Protriptyline plasma levels and antidepressant response. Clin. Pharmacol. Ther., 22, 269–73
Cohen, B.M., Lipinski, J.F., Pope, G., Harris, P.Q. and Altesman, R.K. (1980). Neuroleptic blood levels and therapeutic effects. Psychopharmacologia, 70, 191–3
Dasberg, H.J., van der Kleijn, E., Guelen, P.J.R. and van Praag, H.M. (1974). Plasma concentrations of diazepam and of its metabolite N-desmethyl-diazepam in relation to anxiolytic effect. Clin. Pharmacol. Ther., 15, 473–83
Della Corte, L., Broadhurst, A.D., Sgaragli, G.P., Filippini, S., Heeley, A.F., James, H.D., Faravelli, C. and Pazzogli, A. (1979). Clinical response and tricyclic plasma levels during treatment with clomipramine. Br. J. Psychiatry, 134, 390–400
Garver, D.L., Dekirmenjian, H., Davis, J.M., Casper, R. and Ericksen, S. (1977). Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine. Am. J. Psychiatry, 134, 304–7
Glassman, A.H., Perel, J.M., Shostak, M., Kantor, S.J. and Fliess, J.L. (1977). Clinical implications of imipramine plasma levels for depressive illness. Arch. Gen. Psychiatry, 34, 197–204
Kragh-Sørensen, P., Hansen, C.E., Baastrup, P.C. and Hvidberg, E.F. (1976). Self-inhibiting action of nortriptyline’s antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression. Psychopharmacologia, 45, 305–12
Kupfer, D.J., Hanin, I., Spike, D.G., Grau, T. and Coble, P. (1977). Amitriptyline plasma levels and clinical response in primary depression. Clin. Pharmacol. Ther., 22, 904–11
Magliozzi, J.R., Hollister, L.E., Kathryn, A.V. and Earle, G.M. (1981). Relationship of serum haloperidol levels to clinical response in schizophrenic patients. Am. J. Psychiatry, 138, 365–7
Montgomery, S., Braithwaite, R.A., Dawling, S. and McAuley, R. (1978). High plasma nortriptyline levels in the treatment of depression. Clin. Pharmacol. Ther., 23, 309–14
Pinder, R.M., Brogden, R.N., Speight, T.M. and Avery, G.S. (1977). Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs, 13, 321–52
Reisby, N., Gram, L.F., Bech, P., Nagy, A., Petersen, G.O., Ortmann, J., Ibsen, I., Dencker, S.J., Jacobsen, O., Krautwald, O., Sondergaard, I. and Christiansen, J. (1977). Imipramine clinical effects and pharmacokinetic variability. Psychopharmacology, 54, 263–7
Rivera-Calimlim, L., Nasrallah, H., Strauss, J. and Lasagna, L. (1976). Clinical response and plasma levels: effects of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. Am. J. Psychiatry, 133, 646–52
Rivera-Calimlin, L., Griesbach, P.H. and Perlmutter, R. (1979). Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness. Clin. Pharmacol. Ther., 26, 114–21
Stern, R.S., Marks, I.M., Wright, J. and Luscombe, D.K. (1980). Clomipramine plasma levels, side effects and outcome in obsessive-compulsive neurosis. Postgrad. Med. J., 56, Suppl. 1, 134–9
Vandel, S., Vandel, B., Sandoz, M., Allers, G., Bechtel, P. and Volmat, R. (1978). Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. Eur. J. Clin. Pharmacol., 14, 185–90
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1983 The contributors
About this chapter
Cite this chapter
Hollister, L.E. (1983). Overview: measuring plasma concentrations of psychotherapeutic drugs. In: Gram, L.F., Usdin, E., Dahl, S.G., Kragh-Sørensen, P., Sjöqvist, F., Morselli, P.L. (eds) Clinical Pharmacology in Psychiatry. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06671-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-349-06671-1_12
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06673-5
Online ISBN: 978-1-349-06671-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)